2022 Form 10-K Financial Statement

#000121390022022425 Filed on April 29, 2022

View on sec.gov

Income Statement

Concept 2022 2021 Q1 2021
Revenue $1.422M $348.1K $943.7K
YoY Change 50.7% 1677.78% 154.61%
Cost Of Revenue $917.8K $161.7K $582.4K
YoY Change 57.6% 28.12% 6.06%
Gross Profit $504.3K $186.4K $361.3K
YoY Change 39.57% -274.74% -302.47%
Gross Profit Margin 35.46% 53.54% 38.29%
Selling, General & Admin $4.023M $2.368M $2.957M
YoY Change 36.03% 364.83% 65.12%
% of Gross Profit 797.69% 1270.69% 818.46%
Research & Development $411.4K
YoY Change
% of Gross Profit 81.57%
Depreciation & Amortization $308.7K $76.55K $160.1K
YoY Change 92.83% 324.1% 121.79%
% of Gross Profit 61.22% 41.08% 44.31%
Operating Expenses $4.434M $2.368M $0.00
YoY Change 364.83% -100.0%
Operating Profit -$3.930M -$2.182M $361.3K
YoY Change -1187.65% 254.12% -118.35%
Interest Expense -$118.4K -$73.85K -$258.6K
YoY Change -54.21% -184.71% -1771.56%
% of Operating Profit -71.57%
Other Income/Expense, Net $6.615M $0.00
YoY Change -100.0%
Pretax Income -$6.176M -$2.252M -$2.933M
YoY Change 110.59% 138.47% 7.76%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.176M -$2.252M -$2.933M
YoY Change 110.59% 138.47% 7.76%
Net Earnings / Revenue -434.28% -647.02% -310.78%
Basic Earnings Per Share -$0.80
Diluted Earnings Per Share -$778.5K -$312.7K -$435.6K
COMMON SHARES
Basic Shares Outstanding 7.933M shares
Diluted Shares Outstanding 7.933M shares

Balance Sheet

Concept 2022 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.892M $152.0K $152.0K
YoY Change 3118.55% 1393.03% 1393.03%
Cash & Equivalents $4.892M $152.0K $152.0K
Short-Term Investments
Other Short-Term Assets $370.5K
YoY Change
Inventory $131.7K $52.85K $52.85K
Prepaid Expenses
Receivables $71.38K $109.4K $109.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.465M $314.2K $314.2K
YoY Change 1639.51% 627.63% 627.63%
LONG-TERM ASSETS
Property, Plant & Equipment $998.3K $1.077M $1.077M
YoY Change -7.27% 792.43% 792.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.274M $9.613M $9.613M
YoY Change -24.33% 346.18% 346.18%
TOTAL ASSETS
Total Short-Term Assets $5.465M $314.2K $314.2K
Total Long-Term Assets $7.274M $9.613M $9.613M
Total Assets $12.74M $9.927M $9.927M
YoY Change 28.33% 351.71% 351.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $639.5K $940.6K $940.6K
YoY Change -32.01% 21.85% 21.85%
Accrued Expenses $19.33K $0.00 $0.00
YoY Change -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.403M $1.403M
YoY Change -100.0% 350.15% 1352.34%
Long-Term Debt Due $14.12K $138.6K $138.6K
YoY Change -89.81% -35.52% -35.52%
Total Short-Term Liabilities $779.3K $2.569M $2.569M
YoY Change -69.66% 27.01% 27.01%
LONG-TERM LIABILITIES
Long-Term Debt $101.1K $246.9K $246.9K
YoY Change -59.04%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $101.1K $246.9K $246.9K
YoY Change -59.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $779.3K $2.569M $2.569M
Total Long-Term Liabilities $101.1K $246.9K $246.9K
Total Liabilities $880.4K $2.815M $2.815M
YoY Change -68.73% 39.22% 39.22%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.86M $7.112M $7.112M
YoY Change
Total Liabilities & Shareholders Equity $12.74M $9.927M $9.927M
YoY Change 28.33% 351.71% 351.71%

Cashflow Statement

Concept 2022 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$6.176M -$2.252M -$2.933M
YoY Change 110.59% 138.47% 7.76%
Depreciation, Depletion And Amortization $308.7K $76.55K $160.1K
YoY Change 92.83% 324.1% 121.79%
Cash From Operating Activities -$2.809M -$83.15K -$297.1K
YoY Change 845.67% -29.26% -66.79%
INVESTING ACTIVITIES
Capital Expenditures -$81.60K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $66.99K
YoY Change -100.0%
Cash From Investing Activities -$81.60K $0.00 $66.99K
YoY Change -221.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.631M 41.74K 371.9K
YoY Change 1951.98% 37.98% -13.57%
NET CHANGE
Cash From Operating Activities -2.809M -83.15K -297.1K
Cash From Investing Activities -81.60K 0.000 66.99K
Cash From Financing Activities 7.631M 41.74K 371.9K
Net Change In Cash 4.740M -41.41K 141.8K
YoY Change 3242.64% -52.56% -130.55%
FREE CASH FLOW
Cash From Operating Activities -$2.809M -$83.15K -$297.1K
Capital Expenditures -$81.60K
Free Cash Flow -$2.728M -$297.1K
YoY Change 818.21% -66.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001676047
CY2022Q1 ntrb Subscription Payables
SubscriptionPayables
USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
USD
CY2022 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
USD
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
USD
CY2022 ntrb Stock Issued During Period Cashless Exercise Of Warrants
StockIssuedDuringPeriodCashlessExerciseOfWarrants
USD
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
USD
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
USD
CY2022 ntrb Early Prepayment Fee On Convertible Debentures
EarlyPrepaymentFeeOnConvertibleDebentures
USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
USD
CY2022 ntrb Proceeds From Stock Subscription
ProceedsFromStockSubscription
USD
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
USD
CY2021 ntrb Payment On Related Party Note Payable
PaymentOnRelatedPartyNotePayable
USD
CY2021 ntrb Purchase Of Treasury Stock
PurchaseOfTreasuryStock
USD
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
USD
CY2021 ntrb Common Stock Issued For Prepaid Consulting
CommonStockIssuedForPrepaidConsulting
USD
CY2021 ntrb Noncash Payment For License Agreement
NoncashPaymentForLicenseAgreement
USD
CY2022 ntrb Derivative Liability Warrant Reclassed To Equity
DerivativeLiabilityWarrantReclassedToEquity
USD
CY2021 ntrb Common Stock Issued For Subscription Payable
CommonStockIssuedForSubscriptionPayable
USD
CY2022 ntrb Common Stock And Note Issued In Acquisitions
CommonStockAndNoteIssuedInAcquisitions
USD
CY2021 ntrb Settlement Of Liabilities For Common Stock
SettlementOfLiabilitiesForCommonStock
USD
CY2021 ntrb Deemed Dividend In Connection With Warrant Round Down
DeemedDividendInConnectionWithWarrantRoundDown
USD
CY2021 ntrb Cashless Exercise Of Warrant
CashlessExerciseOfWarrant
USD
CY2021 us-gaap Stock Issued1
StockIssued1
USD
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
USD
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
USD
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
USD
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021 ntrb Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Averages Remaining Contractual Term2 Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAveragesRemainingContractualTerm2Granted
CY2021 ntrb Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGrantDateIntrinsicValue
USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q1 ntrb Exercise Price Outstanding
ExercisePriceOutstanding
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2022 ntrb Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGrantDateIntrinsicValue
USD
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022 ntrb Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrices
CY2022 ntrb Stock Issued During Period Shares Stock Options Shares Exercised
StockIssuedDuringPeriodSharesStockOptionsSharesExercised
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022 ntrb Share Based Compensation Arrangements By Share Based Payment Remaining Life Exercised
ShareBasedCompensationArrangementsByShareBasedPaymentRemainingLifeExercised
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
USD
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
USD
CY2022 ntrb Subscription Payable
SubscriptionPayable
USD
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2020Q1 ntrb Exercise Price Outstanding
ExercisePriceOutstanding
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2021 ntrb Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrices
CY2021 ntrb Stock Issued During Period Shares Stock Options Shares Exercised
StockIssuedDuringPeriodSharesStockOptionsSharesExercised
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021 ntrb Share Based Compensation Arrangements By Share Based Payment Remaining Life Exercised
ShareBasedCompensationArrangementsByShareBasedPaymentRemainingLifeExercised
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares

Files In Submission

Name View Source Status
0001213900-22-022425-index-headers.html Edgar Link pending
0001213900-22-022425-index.html Edgar Link pending
0001213900-22-022425.txt Edgar Link pending
0001213900-22-022425-xbrl.zip Edgar Link pending
f10k2022ex31-1_nutriband.htm Edgar Link pending
f10k2022ex31-2_nutriband.htm Edgar Link pending
f10k2022ex32-1_nutriband.htm Edgar Link pending
f10k2022_nutribandinc.htm Edgar Link pending
f10k2022_nutribandinc_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntrb-20220131.xsd Edgar Link pending
ntrb-20220131_cal.xml Edgar Link unprocessable
ntrb-20220131_def.xml Edgar Link unprocessable
ntrb-20220131_lab.xml Edgar Link unprocessable
ntrb-20220131_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending